Arkolith/Insider Trading/KMPH/Form 4

Pascoe Richard W

Chief Executive Officer, DirectorKEMPHARM, INC (KMPH) · full profile →Form 4 · filed Jan 13, 2023
Net Buying
Open-Market Buys
$52K
Open-Market Sells
$0
Net Open-Market Flow
$52K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 13, 2023Buy(P)10K$5.44$52K20K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001437749-23-001059) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML